Ulotaront (SEP-363856)
Schizophrenia
Ulotaront (SEP-363856)
Adjunctive major depressive disorder
Ulotaront (SEP-363856)
Generalized anxiety disorder
SEP-4199
Bipolar depression
Ulotaront (SEP-363856)
Parkinson's disease psychosis
DSP-3905
Neuropathic pain
SEP-378614
Treatment-resistant depression
SEP-380135
Agitation in Alzheimer's disease
DSP-0038
Alzheimer's disease psychosis
DSP-3456
Treatment-resistant depression
DSP-2342
To be determined
These are investigational compounds
whose safety and efficacy have not been reviewed or approved by the FDA